{"text": ["Lilly", "(LLY)", "Phase", "III", "Eczema", "Study", "on", "Lebrikizumab", "Meets", "Goal"], "created_at": "2021-08-17 14:11:02"}
{"text": ["Insulet's", "(PODD)", "Omnipod", "Gets", "FDA", "Nod", "for", "Use", "With", "Lyumjev"], "created_at": "2021-08-17 14:08:02"}
{"text": ["The", "Daily", "Biotech", "Pulse:", "Lilly", "Reorganizes", "Business", "Units", "In", "Neuroscience", "Focus,", "Helius", "Medical", "Spikes", "On", "Breakthrough", "Designation,", "Ra", "Medical", "Sells", "Dermatology", "Business"], "created_at": "2021-08-17 12:28:52"}
{"text": ["Eli", "Lilly", "creates", "neuroscience", "and", "immunology", "business", "units"], "created_at": "2021-08-17 10:58:33"}
{"text": ["Lilly", "Announces", "Leadership", "Changes", "and", "Formation", "of", "Neuroscience", "and", "Immunology", "Business", "Units"], "created_at": "2021-08-17 10:30:00"}
